查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1765231

全球智慧药丸市场

Smart Pills
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球智慧药丸市场规模将达到 11 亿美元

全球智慧药丸市场规模预计在2024年为5.505亿美元，预计到2030年将达到11亿美元，在2024-2030年的分析期内，复合年增长率为11.6%。食道是本报告分析的细分市场之一，预计其复合年增长率为12.1%，到分析期结束时将达到2.384亿美元。小肠细分市场在分析期间内的复合年增长率预计为12.5%。

美国市场规模估计为 1.515 亿美元，中国市场预计复合年增长率为 10.8%

美国智慧药丸市场规模预计在2024年达到1.515亿美元。作为世界第二大经济体，中国市场规模预计在2030年达到1.63亿美元，在2024-2030年的分析期间内，复合年增长率为10.8%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为10.2%和9.6%。在欧洲，预计德国市场的复合年增长率约为8.4%。

全球智慧药丸市场－主要趋势与驱动因素摘要

什么是智能药丸？它们将如何彻底改变医疗保健？

智慧药丸配备感测器、摄影机和通讯模组，能够提供服药依从性、生理参数和胃肠道状况的即时数据，从而彻底改变医疗保健产业。这些可吞服的设备越来越多地用于诊断、监测和药物输送，为传统诊断和治疗方法提供了非侵入式的替代方案。智慧药丸允许医疗保健提供者远端监测患者的健康状况，并根据数据做出治疗调整决策，从而实现个人化医疗。它们还能提高患者的服药顺从性，尤其是在糖尿病、心血管疾病和精神疾病等慢性疾病领域。

哪些细分市场引领智慧药丸市场？

这些器官包括食道、小肠、大肠和胃。感测器智慧药丸因其在监测和诊断领域的广泛应用而处于领先地位。应用领域分为胶囊内视镜检查、病患监测和药物输送，其中胶囊内视镜检查因其在胃肠道诊断中的应用日益广泛而占据市场主导地位。终端使用者包括医院和诊所、研究机构和居家医疗，但由于智慧药丸在高级诊断和个人化治疗方案中的应用日益广泛，医院和诊所占据了最大的市场占有率。

哪些趋势将塑造智慧药丸的未来？

智慧药丸市场受多种趋势影响，包括感测器技术、微型化和数据分析的进步。人工智慧和机器学习的融合使智慧药丸能够提供更精准、更具预测性的健康洞察，从而提升诊断和治疗的可能性。人们对数位健康和​​远端医疗的日益关注，推动了对具有远端监控和即时数据传输功能的智慧药丸的需求。此外，个人化医疗的趋势也推动了具有靶向药物传输和反馈机制的智慧药丸的发展。製药公司与科技公司之间的合作正在进一步加速智慧药丸技术的创新。

哪些因素推动了智慧药丸市场的成长？

智慧药丸市场的成长受到多种因素的推动，例如对远端患者监护和数位健康解决方案的需求不断增长、感测器和微型化技术的进步、对个人化医疗和标靶药物输送的日益关注。此外，老年人口的成长和慢性病的流行、远端医疗和数位治疗方法的扩展，以及製药公司和科技公司之间日益增多的合作，也促进了市场的成长。此外，经济高效且用户友好的智慧药丸解决方案的开发、支持性法规结构的完善以及对数位健康技术不断增长的投资，都在推动市场向前发展。

部分

应用（胶囊内视镜、药物传递、病患监测）；最终用途（医院、诊断中心、研究实验室）；目标区域（食道、小肠、大肠、胃）

受访公司范例

  • Capsovision, Inc.
  • Check-Cap Ltd.
  • Hq, Inc.
  • IntroMedic
  • Jinshan Science & Technology（Group）Co., Ltd.
  • Koninklijke Philips NV
  • Medtronic PLC
  • Olympus Corporation
  • Proteus Digital Health, Inc.
  • RF Co., Ltd.

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 并未遵循查询 LLM 或特定产业SLM 的典型规范，而是建立了一个来自全球领域专家的精选内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP14835

Global Smart Pills Market to Reach US$1.1 Billion by 2030

The global market for Smart Pills estimated at US$550.5 Million in the year 2024, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 11.6% over the analysis period 2024-2030. Esophagus, one of the segments analyzed in the report, is expected to record a 12.1% CAGR and reach US$238.4 Million by the end of the analysis period. Growth in the Small Intestine segment is estimated at 12.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$151.5 Million While China is Forecast to Grow at 10.8% CAGR

The Smart Pills market in the U.S. is estimated at US$151.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$163.0 Million by the year 2030 trailing a CAGR of 10.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.2% and 9.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.

Global Smart Pills Market - Key Trends and Drivers Summarized

What Are Smart Pills and How Are They Revolutionizing Healthcare?

Smart pills, equipped with sensors, cameras, and communication modules, are revolutionizing healthcare by providing real-time data on medication adherence, physiological parameters, and gastrointestinal conditions. These ingestible devices are increasingly being used for diagnostic, monitoring, and drug delivery purposes, offering a non-invasive alternative to traditional diagnostic and therapeutic methods. Smart pills are enabling personalized medicine by allowing healthcare providers to monitor patient health remotely and make data-driven decisions for treatment adjustments. They are also improving patient compliance with medication regimens, particularly for chronic diseases such as diabetes, cardiovascular disorders, and mental health conditions.

Which Segments Are Leading in the Smart Pills Market?

Target Areas include esophagus, small intestine, large intestine, and stomach. Sensor-enabled smart pills lead due to their extensive use in monitoring and diagnostics. Applications are categorized into capsule endoscopy, patient monitoring, and drug delivery, with capsule endoscopy dominating the market owing to its growing adoption in gastrointestinal diagnostics. End-users range from hospitals and clinics to research institutions and home care settings, with hospitals and clinics holding the largest market share due to the increasing use of smart pills in advanced diagnostics and personalized treatment plans.

What Trends Are Shaping the Future of Smart Pills?

The smart pills market is being shaped by several trends, including advancements in sensor technologies, miniaturization, and data analytics. The integration of AI and machine learning is enabling smart pills to provide more accurate and predictive health insights, enhancing their diagnostic and therapeutic potential. The rising focus on digital health and telemedicine is driving the demand for smart pills that offer remote monitoring and real-time data transmission. Additionally, the trend towards personalized medicine is spurring the development of smart pills with targeted drug delivery and feedback mechanisms. Collaborations between pharmaceutical companies and tech firms are further accelerating innovation in smart pill technologies.

What Factors Are Driving Growth in the Smart Pills Market?

The growth in the smart pills market is driven by several factors, including the increasing demand for remote patient monitoring and digital health solutions, advancements in sensor and miniaturization technologies, and the rising focus on personalized medicine and targeted drug delivery. The growth in the geriatric population and the prevalence of chronic diseases, the expansion of telemedicine and digital therapeutics, and the increasing collaborations between pharmaceutical and technology companies are also contributing to market growth. Furthermore, the development of cost-effective and user-friendly smart pill solutions, supportive regulatory frameworks, and growing investments in digital health technologies are propelling the market forward.

SCOPE OF STUDY:

The report analyzes the Smart Pills market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring); End-Use (Hospital, Diagnostic Center, Research Institute); Target Area (Esophagus, Small Intestine, Large Intestine, Stomach)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 46 Featured) -

  • Capsovision, Inc.
  • Check-Cap Ltd.
  • Hq, Inc.
  • IntroMedic
  • Jinshan Science & Technology (Group) Co., Ltd.
  • Koninklijke Philips NV
  • Medtronic PLC
  • Olympus Corporation
  • Proteus Digital Health, Inc.
  • RF Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Smart Pills - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Focus on Remote Patient Monitoring and Healthcare Automation Drives Market Growth
    • Advancements in Sensor Technologies and Miniaturization Propel Smart Pills Market Expansion
    • Rising Demand for Personalized Medicine Strengthens Business Case for Smart Pills
    • Growth in Geriatric Population and Chronic Disease Management Spurs Adoption
    • Development of Smart Pills with Real-Time Data Transmission and Feedback Enhances Market Competitiveness
    • Integration with AI and Big Data Analytics in Healthcare Expands Addressable Market Opportunity
    • Emergence of Smart Pills with Ingestible Sensors for Drug Delivery and Diagnostics Generates New Opportunities
    • Rising Interest in Digital Health and Telemedicine Solutions Supports Market Growth
    • Focus on Enhancing Patient Adherence and Treatment Outcomes Propels Demand for Smart Pills
    • Growing Applications in Clinical Trials and Therapeutic Monitoring Accelerate Market Adoption
    • Development of User-Friendly, Patient-Centric Smart Pills Supports Market Differentiation
    • Need for Integration with Broader Digital Health Ecosystems Drives Market Evolution
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Smart Pills Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Smart Pills by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Smart Pills by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Esophagus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Esophagus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Small Intestine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Small Intestine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Large Intestine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Large Intestine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Stomach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Stomach by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Capsule Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Capsule Endoscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Patient Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Patient Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Hospital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic Center by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Diagnostic Center by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Research Institute by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Research Institute by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 24: USA Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • CANADA
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • JAPAN
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • CHINA
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 42: China Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • EUROPE
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Smart Pills by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Smart Pills by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • FRANCE
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • GERMANY
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • UNITED KINGDOM
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030

IV. COMPETITION